5 completed, 4 terminated, 2 active not recruiting, 1 recruiting. 5 Phase 1, 3 Not applicable, 3 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Terminated 2, Recruiting 1 |
| Not applicable | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Early Phase 1 | 1 | Terminated 1 |
Follow Stage I Renal Cell Cancer: new trials by email Literature Review of Stage I Renal Cell Cancer trials Research Report on Stage I Renal Cell Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prehabilitation Prior to Surgery for Kidney Tumors Prehabilitation - Renal Cancer, Renal Cell Cancer | Not applicable | Active not recruiting | Herlev and Gentofte Hospital | 60 | 2025-01-21 | 2026-09-02 |
| Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial Angiogram, Biospecimen Collection, Computed Tomography - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 25 | 2024-12-26 | 2026-08-21 |
| Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer Interstitial Radiation Therapy - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Phase 1 | Terminated | Jonsson Comprehensive Cancer Center | 2 | 2020-07-16 | 2026-08-20 |
| Enzalutamide Before Surgery in Treating Patients With Kidney Cancer Enzalutamide, Laboratory Biomarker Analysis, Nephrectomy - Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer | Early Phase 1 | Terminated | Rutgers, The State University of New Jersey | 3 | 2017-12-05 | 2021-09-16 |
| sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Radical Cystectomy - Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma | Phase 1 | Terminated | University of Southern California | 2 | 2016-08-02 | 2021-11-24 |
| Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer Computed Tomography, Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - Healthy Subject, Metastatic Renal Cell Cancer | Active not recruiting | University of Southern California | 37 | 2015-09-08 | 2026-04-02 | |
| Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors Arterial Spin Labeling Magnetic Resonance Imaging, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging - Stage I Renal Cell Cancer, Stage II Renal Cell Cancer | Not applicable | Completed | Rutgers, The State University of New Jersey | 75 | 2015-04-01 | 2026-06-02 |
| Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer Laboratory Biomarker Analysis, Nephrectomy, Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003 - Recurrent Renal Cell Carcinoma, Stage I Renal Cell Cancer | Not applicable | Terminated | Roswell Park Cancer Institute | 5 | 2014-10-14 | 2020-07-07 |
| Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors fluorescence imaging, laparoscopic surgery, indocyanine green - Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer | Phase 1 | Completed | City of Hope Medical Center | 28 | 2011-10-20 | 2017-10-13 |
| Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies sunitinib malate, bevacizumab, pharmacological study - Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 6 | 2010-10-01 | 2014-04-02 |
| Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer pazopanib hydrochloride, therapeutic conventional surgery - Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer | Phase 2 | Completed | Case Comprehensive Cancer Center | 25 | 2010-06-01 | 2018-09-12 |
| Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Doxorubicin Hydrochloride, Irinotecan Hydrochloride, Conventional Surgery - Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | Phase 2 | Completed | Children's Oncology Group | 291 | 2006-06-01 | 2017-07-21 |
Carcinoma, Renal Cell (12) · Kidney Neoplasms (1) · Prostatic Neoplasms (1) · Urinary Bladder Neoplasms (1) · Wilms Tumor (1)
Adenocarcinoma (12) · Carcinoma (12) · Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Kidney Diseases (12) · Male Urogenital Diseases (12) · Neoplasms (12) · Neoplasms by Histologic Type (12) · Neoplasms by Site (12) · Neoplasms, Glandular and Epithelial (12) · Urogenital Diseases (12) · Urogenital Neoplasms (12) · Urologic Diseases (12) · Urologic Neoplasms (12) · Kidney Neoplasms (11)
Magnetic Resonance Spectroscopy (2) · Nephrectomy (2) · 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1) · Bevacizumab (1) · Brachytherapy (1) · Carboplatin (1) · Congresses as Topic (1) · Cyclophosphamide (1) · Cystectomy (1) · Dactinomycin (1) · Doxorubicin (1) · Etoposide (1) · Exercise (1) · Geriatric Assessment (1) · Indocyanine Green (1)
Jonsson Comprehensive Cancer Center (2) · Rutgers, The State University of New Jersey (2) · University of Southern California (2) · Case Comprehensive Cancer Center (1) · Children's Oncology Group (1) · City of Hope Medical Center (1) · Herlev and Gentofte Hospital (1) · National Cancer Institute (NCI) (1) · Roswell Park Cancer Institute (1)
United States (11) · Australia (1) · Canada (1) · Denmark (1) · New Zealand (1) · Puerto Rico (1)
Albert J Chang (1) · Brian Rini (1) · Clayton Lau, MD (1) · David Foran (1) · David I Quinn, MD (1) · Eric Singer (1) · Glenn Liu (1) · Jacek Pinski, MD (1) · Jeffrey Dome, MD (1) · Siddharth A Padia (1)
PMID 25532471, PMID 38396300, PMID 41276366, PMID 41592385
P30CA014089 (2), P30CA072720 (2), P30CA014520 (1), P30CA016056 (1), U01CA062491 (1), U01CA070095 (1), U10CA098543 (1)